Correction: AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway

• Yizhi Zhang,
• Wan Li,
• Yihui Yang,
• Sen Zhang,
• Hong Yang,
• Yue Hao,
• Xu Fang,
• Guanhua Du,
• Jianyou Shi,
• Lianqiu Wu,
• Jinhua Wang

Affiliations

Yizhi Zhang

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Wan Li

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Yihui Yang

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Sen Zhang

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Hong Yang

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Yue Hao

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Xu Fang

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Guanhua Du

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines

Jianyou Shi

Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China

Lianqiu Wu

Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College

Jinhua Wang

The State Key Laboratory of Bioactive Substance and Function of Natural Medicines